Other languages Valeo Pharma Inc. Canadian Securities Exchange

Equities

VPH

CA91915B1085

Delayed Canadian Securities Exchange Other stock markets 01:27:37 29/03/2022 am IST			5-day change	1st Jan Change
0.66 ^CAD	-.--%		+1.54%	-10.81%

25/04	Transcript : Valeo Pharma Inc. - Shareholder/Analyst Call
22/03	Valeo Pharma Inc. Announces Appointment of Al Moghaddam to Board of Directors	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Valeo Pharma Inc. Announces Appointment of Al Moghaddam to Board of Directors	22/03
Valeo Pharma Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	15/03
Valeo Pharma Inc. Announces Board Changes	13/02
Valeo Pharma Amends Agreement with Novartis Pharmaceuticals Canada for (Pr)XIIDRA in Canada	03/02
Valeo Pharma's Q4'23 Net Loss Holds Steady YOY	30/01
Valeo Pharma Inc. Reports Earnings Results for the Full Year Ended October 31, 2023	30/01
LSL Pharma Group Appoints Luc Mainville as Chief Financial Officer	04/12
Valeo Pharma Announces Organizational Changes and Cost Reduction Initiatives; Shares Jumped Near 30% Friday	20/11
Valeo Pharma Inc. Announces Appointment of Mr. Richard Lajoie to Board of Directors	07/11
Valeo Pharma's Fiscal Q3 Loss Widens, Revenue Grows; Up 3.5%	14/23/14
Valeo Pharma's Fiscal Q3 Loss Widens, Revenue Grows	14/23/14
Valeo Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	14/23/14
Valeo Pharma's Fiscal Q2 Loss Widens; Revenue Grows	14/23/14
Valeo Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	14/23/14
Valeo Pharma Edging Up After Providing Guidance of Record Revenues for Q2 2023	25/23/25
Valeo Pharma Inc. Announces Management Changes	28/23/28
Valeo Pharma Inc. Provides Earnings Guidance for the Year 2023	27/23/27
Valeo Pharma Obtains Public Reimbursement for Onstryv in Quebec	07/23/07
Valeo Pharma Inc. Reports Earnings Results for the Full Year Ended October 31, 2022	31/23/31
Valeo Pharma Fourth-Quarter Loss Widens as Revenue Climbs to a Record	31/23/31

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Valeo Pharma Inc. Canadian Securities Exchange

Equities

VPH

CA91915B1085

Other languages

Filters